comparemela.com

Latest Breaking News On - Bioscience corporation - Page 5 : comparemela.com

Insider Selling: Twist Bioscience Co. (NASDAQ:TWST) CEO Sells 4,163 Shares of Stock

Insider Selling: Twist Bioscience Co. (NASDAQ:TWST) CEO Sells 4,163 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Robertw-baird
Emilym-leproust
Nasdaq
Hermes-inc
Goldman-sachs-group
Barclays
Allspring-global-investments-holdings
Twist-bioscience-co
International-assets-investment-management
Edgerock-capital

Twist Bioscience (NASDAQ:TWST) Price Target Raised to $50.00

Twist Bioscience (NASDAQ:TWST – Free Report) had its price target boosted by Evercore ISI from $46.00 to $50.00 in a report issued on Friday morning, Benzinga reports. Evercore ISI currently has an outperform rating on the stock. Several other brokerages also recently issued reports on TWST. Robert W. Baird lifted their price objective on Twist […]

Zurcher-kantonalbank-zurich-cantonalbank
Emilym-leproust
Robertw-baird
Scotiabank
Allspring-global-investments-holdings
Td-asset-management-inc
Goldman-sachs-group
Twist-bioscience-corporation
Rockland-trust-co
Barclays
Twist-bioscience
Free-report

Twist Bioscience (NASDAQ:TWST) PT Raised to $48.00 at Scotiabank

Twist Bioscience (NASDAQ:TWST – Get Free Report) had its target price lifted by investment analysts at Scotiabank from $43.00 to $48.00 in a report released on Monday, Benzinga reports. The firm presently has a “sector outperform” rating on the stock. Scotiabank’s target price would indicate a potential upside of 7.43% from the company’s current price. […]

China
Emilym-leproust
Robertw-baird
Patrick-john-finn
Hermes-inc
Twist-bioscience-corporation
Goldman-sachs-group
Barclays
Edgerock-capital
Twist-bioscience-company-profile
Securities-exchange-commission
Allspring-global-investments-holdings

Twist Bioscience (NASDAQ:TWST) Price Target Increased to $48.00 by Analysts at Scotiabank

Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price target lifted by Scotiabank from $43.00 to $48.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “sector outperform” rating on the stock. Scotiabank’s price objective would indicate a potential upside of 7.43% from the company’s current price. Several other equities […]

United-kingdom
Robertw-baird
Emilym-leproust
Twist-bioscience-company-profile
Securities-exchange-commission
Barclays
Artisan-partners-limited-partnership
Invesco-ltd
Investment-management
Goldman-sachs-group
Twist-bioscience-corporation

Evercore ISI Raises Twist Bioscience (NASDAQ:TWST) Price Target to $50.00

Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price objective hoisted by investment analysts at Evercore ISI from $46.00 to $50.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Evercore ISI’s target price would indicate a potential upside of […]

Florida
United-states
Patrick-john-finn
Robertw-baird
Emilym-leproust
Goldman-sachs-group
Twist-bioscience-corporation
Barclays
Board-of-administration-florida-retirement-system
Scotiabank
Charles-schwab-investment-management-inc
Citigroup-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.